GSK, PLC
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated . These are the last published financial totals; newer source data is not included yet.
A current recipient-party breakdown has not been published. Financial totals remain available; older party percentages are not shown.
Loading 10 contributions with dates…
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under GSK, PLC.
Showing the last published contribution snapshot. Newer source data is not included yet.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for GSK plc. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 1–10 of 499 · largest absolute amount first
Reported name + ZIP cluster; not a verified identity merge · PHILADELPHIA, PA, 19112 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · PRESIDENT, US · 38 transaction rows
Reported name + ZIP cluster; not a verified identity merge · DURHAM, NC, 27709 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · VICE PRESIDENT, RESPIRATORY SALES · 38 transaction rows
Evidence-based cluster of 2 reported identities; not a verified identity merge · SCOTCH PLAINS, NJ, 07076 · GSK · Healthcare & Pharmaceuticals · DRUG DEVELOPMENT · Reported as GUIDI, JOSEPH / GUIDI, JOSEPH M. · 39 transaction rows
Evidence-based cluster of 2 reported identities; not a verified identity merge · WASHINGTON, DC, 20004 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · PUBLIC POLICY · 32 transaction rows
Reported name + ZIP cluster; not a verified identity merge · YOUNGSVILLE, NC, 27596 · GSK · Healthcare & Pharmaceuticals · DIRECTOR, SOLUTIONS DELIVERY · 1 transaction rows
Reported name + ZIP cluster; not a verified identity merge · WASHINGTON, DC, 20009 · GSK · Healthcare & Pharmaceuticals · STATISTICS LEADER · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · WASHINGTON, DC, 20004 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · GOVERNMENT RELATIONS · 19 transaction rows
Reported name + ZIP cluster; not a verified identity merge · WASHINGTON, DC, 20004 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · ASSISTANT GENERAL COUNSEL · 36 transaction rows
Reported name + ZIP cluster; not a verified identity merge · DURHAM, NC, 27709 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · RX ACCOUNT MANAGEMENT ONCOLOGY · 34 transaction rows
Reported name + ZIP cluster; not a verified identity merge · COLLEGEVILLE, PA, 19426 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · VP, GLOBAL PRICING & MARKET ACCESS HEA · 34 transaction rows
Where the contributions went · 10 per page
Showing 1–10 of 68 · largest absolute amount first
PAC (qualified) · WASHINGTON, DC · 5,192 transaction rows
PAC (not qualified) · RALEIGH, NC · 20 transaction rows
Party committee (qualified) · WASHINGTON, DC · 37 transaction rows
PAC (qualified) · WASHINGTON, DC · 1 transaction rows
House campaign committee · ARLINGTON, VA · MCCLURE, ADELE · U.S. House VA 07 · 2 transaction rows
House campaign committee · MOUNTAINSIDE, NJ · ROTH, MICHAEL · U.S. House NJ 07 · 6 transaction rows
Senate campaign committee · AUSTIN, TX · TALARICO, JAMES · U.S. Senate TX 00 · 30 transaction rows
Senate campaign committee · OVERLAND PARK, KS · PARELKAR, LOIS ANNE ELIZABETH LEA · U.S. Senate KS 00 · 4 transaction rows
Party committee (qualified) · WASHINGTON, DC · 15 transaction rows
PAC with non-contribution account · CHEYENNE, WY · 5 transaction rows
Reported as GSK, PLC
Industry classification summary
GlaxoSmithKline plc rebranded to GSK plc in 2022 and is a multinational biopharmaceutical company specializing in medicines and vaccines.
AI classification auto-approved under admin authorization
View sourceIndividual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Showing the last published contribution records; newer source data is not included yet.
Largest contribution amounts first. Select Date of contribution or Amount to reverse the order.
| Date of contribution ↕ | Amount ↓ | Reported contributor / location | Recipient / filing |
|---|---|---|---|
| 2026-05-20FEC filing ↗ | $250 | GUIDI, JOSEPHSCOTCH PLAINSNJ07076DRUG DEVELOPMENTGSK | ACTBLUEC00401224Primary (P)EARMARKED FOR MICHAEL ROTH FOR CONGRESS (C00902643)Filing 1986105 |
| 2026-05-21FEC filing ↗ | $250 | LEAL, TOMAS JRPHILADELPHIAPA19107R & D INCLUSION STRATEGY LEADGLAXOSMITHKLINE, LLC | TALARICO FOR TEXASC00919084General 2026 (G2026)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1997887 |
| 2026-05-27FEC filing ↗ | $250 | LEAL, TOMAS JRPHILADELPHIAPA19107R & D INCLUSION STRATEGY LEADGLAXOSMITHKLINE, LLC | MANNY RUTINEL FOR CONGRESSC00896670Primary 2026 (P2026)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1985081 |
| 2026-05-27FEC filing ↗ | $250 | LEAL JR, TOMASPHILADELPHIAPA19107R&D INCLUSION STRATEGY LEADGLAXOSMITHKLINE, LLC | ACTBLUEC00401224Primary (P)EARMARKED FOR MANNY RUTINEL FOR CONGRESS (C00896670)Filing 1986105 |
| 2026-04-21FEC filing ↗ | $250 | GUIDI, JOSEPHSCOTCH PLAINSNJ07076DRUG DEVELOPMENTGSK | ACTBLUEC00401224Primary (P)EARMARKED FOR SPEAK UP PAC (C00885137)Filing 1977432 |
| 2026-04-22FEC filing ↗ | $250 | GUIDI, JOSEPHSCOTCH PLAINSNJ07076DRUG DEVELOPMENTGSK | SPEAK UP PACC00885137Primary (P)* EARMARKED CONTRIBUTION THROUGH ACTBLUE ON 04/26/2026Filing 1999705 · amended |
| 2026-05-07FEC filing ↗ | $250 | FOLEY, LIZELYNCALIFONNJ07830EXECUTIVEGSK | DNC SERVICES CORP / DEMOCRATIC NATIONAL COMMITTEEC00010603General 2026 (G2026)* EARMARKED CONTRIBUTION: SEE BELOWFiling 2003519 · amended |
| 2026-05-07FEC filing ↗ | $250 | FOLEY, LIZELYNCALIFONNJ07830EXECUTIVEGSK | ACTBLUEC00401224Primary (P)EARMARKED FOR DEMOCRATIC NATIONAL COMMITTEE (C00010603)Filing 1986105 |
| 2026-06-30FEC filing ↗ | $250 | LEAL, TOMAS JRPHILADELPHIAPA19107R & D INCLUSION STRATEGY LEADGLAXOSMITHKLINE, LLC | TALARICO FOR TEXASC00919084General 2026 (G2026)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1997887 |
| 2026-06-30FEC filing ↗ | $250 | LEAL JR, TOMASPHILADELPHIAPA19107R&D INCLUSION STRATEGY LEADGLAXOSMITHKLINE, LLC | ACTBLUEC00401224Primary (P)EARMARKED FOR TALARICO FOR TEXAS (C00919084)Filing 2000535 |
Refunds remain negative. Memo-only rows are marked and are not additional money. Rows come from the latest available contribution publication.
Open full contribution table →